Balyasny Asset Management’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-23,643
| Closed | -$684K | – | 2733 |
|
|
2022
Q2 | $684K | Sell |
23,643
-123,826
| -84% | -$3.58M | ﹤0.01% | 1495 |
|
|
2022
Q1 | $4.77M | Buy |
+147,469
| New | +$4.77M | 0.02% | 760 |
|
|
2020
Q3 | – | Sell |
-18,475
| Closed | -$439K | – | 1345 |
|
|
2020
Q2 | $439K | Buy |
18,475
+1,759
| +11% | +$41.8K | ﹤0.01% | 775 |
|
|
2020
Q1 | $301K | Sell |
16,716
-604
| -3% | -$10.9K | ﹤0.01% | 866 |
|
|
2019
Q4 | $411K | Buy |
+17,320
| New | +$411K | ﹤0.01% | 913 |
|
|
2018
Q3 | – | Sell |
-4,024
| Closed | -$241K | – | 1750 |
|
|
2018
Q2 | $241K | Sell |
4,024
-1,375
| -25% | -$82.4K | ﹤0.01% | 1406 |
|
|
2018
Q1 | $247K | Buy |
+5,399
| New | +$247K | ﹤0.01% | 1495 |
|
|
2017
Q4 | – | Sell |
-145,625
| Closed | -$5.83M | – | 1991 |
|
|
2017
Q3 | $5.83M | Buy |
145,625
+140,836
| +2,941% | +$5.63M | 0.02% | 549 |
|
|
2017
Q2 | $206K | Buy |
+4,789
| New | +$206K | ﹤0.01% | 1180 |
|
|
2016
Q4 | – | Sell |
-110,847
| Closed | -$2.74M | – | 1276 |
|
|
2016
Q3 | $2.74M | Buy |
+110,847
| New | +$2.74M | 0.02% | 580 |
|